Semen Polymorphonuclear Neutrophil Leukocyte Elastase as a Diagnostic and Prognostic Marker of Genital Tract Inflammation – A Review
-
Branko Zorn
, Alenka Sešek-Briški , Joško Osredkar und Helena Meden-Vrtovec
Abstract
Elastase is a protease released by polymorphonuclear neutrophils (PMN) during the inflammatory process. Since 1987, seminal elastase-inhibitor complex (Ela/α1-PI) has been proposed as a marker of male silent genital tract inflammation. Measured by immunoassay in seminal plasma, Ela/α1-PI at a cut-off level of ≥230 μg/l, is useful in the detection of genital tract inflammation. The prevalence of increased seminal Ela/α1-PI in infertile men is significantly higher than that observed in fertile men. The Ela/α1-PI level is positively correlated with other seminal fluid markers of male genital tract inflammation: reduced semen volume, citric acid, fructose, and increased albumin, complement component C3, caeruloplasmin, immunoglobulins IgG and IgA, and cytokines interleukins-8 and -6. A higher seminal Ela/α1-PI level is significantly associated with tubal damage in female partners. After antibiotic therapy, a decrease of Ela/α1-PI level is observed. The presence of tubal damage in the partner may negatively affect the response to antibiotic treatment. A higher seminal Ela/α1-PI is associated with lower percentage of sperm with single-stranded deoxyribonucleic acid (DNA) and better fertilization rate in in vitro fertilization. Besides infertility, the determination of Ela/α1-PI is useful to confirm the presence of prostate and other male accessory gland bacterial inflammation. Screening for PMN Ela/α1-PI is easy to perform and reproducible and is a reliable quantitative test for diagnosis and prognosis of silent genital tract inflammation of couples. Moreover, sequential determinations allow the follow-up of inflammation during and after therapy.
Copyright © 2003 by Walter de Gruyter GmbH & Co. KG
Artikel in diesem Heft
- Evidence-Based Laboratory Medicine: Addressing Bias, Generalisability and Applicability in Studies on Diagnostic Accuracy. The STARD Initiative
- Semen Polymorphonuclear Neutrophil Leukocyte Elastase as a Diagnostic and Prognostic Marker of Genital Tract Inflammation – A Review
- Total Oxyradical Scavenging Capacity toward Different Reactive Oxygen Species in Seminal Plasma and Sperm Cells
- Identification of New Polymorphisms in the CACNA1S Gene
- 3-Nitrotyrosine in Atherosclerotic Blood Vessels
- Molecular Diagnosis of Cystic Fibrosis: Comparison of Four Analytical Procedures
- Assessment of Intestinal Permeability: Enzymatic Determination of Urinary Mannitol, Raffinose, Sucrose and Lactose on Hitachi Analyzer
- Effects of Calcium Carbonate, Magnesium Oxide and Sodium Citrate Bicarbonate Health Supplements on the Urinary Risk Factors for Kidney Stone Formation
- Glycerol Metabolism and the Determination of Triglycerides –Clinical, Biochemical and Molecular Findings in Six Subjects
- Plasma Lipid Composition and LDL Oxidation
- Modified Method to Measure Nasal Potential Difference
- Towards Complete and Accurate Reporting of Studies of Diagnostic Accuracy: The STARD Initiative
- Novel and Traditional Biomarkers of Bone Turnover in Postmenopausal Women
- Urinary Plasma Protein Patterns in Acute Prostatitis
- Adequate Sampling in Cryoglobulinaemia: Recommended Warmly
- A New Modification of the Chiron ACS Assay for Total Prostate-Specific Antigen Achieves Equimolar Response Characteristics and Improves the Detection of Prostate Cancer
- Technical Performance and Diagnostic Utility of the New Elecsys® Neuron-Specific Enolase Enzyme Immunoassay
- Measurements of Complement Factor H-Related Protein (BTA-TRAK™ Assay) and Nuclear Matrix Protein (NMP22 Assay) – Useful Diagnostic Tools in the Diagnosis of Urinary Bladder Cancer?
- Erratum: The 18th International Congress of Clinical Chemistry and Laboratory Medicine. Special Supplement Abstracts Issue 2002
- Meetings and Awards
Artikel in diesem Heft
- Evidence-Based Laboratory Medicine: Addressing Bias, Generalisability and Applicability in Studies on Diagnostic Accuracy. The STARD Initiative
- Semen Polymorphonuclear Neutrophil Leukocyte Elastase as a Diagnostic and Prognostic Marker of Genital Tract Inflammation – A Review
- Total Oxyradical Scavenging Capacity toward Different Reactive Oxygen Species in Seminal Plasma and Sperm Cells
- Identification of New Polymorphisms in the CACNA1S Gene
- 3-Nitrotyrosine in Atherosclerotic Blood Vessels
- Molecular Diagnosis of Cystic Fibrosis: Comparison of Four Analytical Procedures
- Assessment of Intestinal Permeability: Enzymatic Determination of Urinary Mannitol, Raffinose, Sucrose and Lactose on Hitachi Analyzer
- Effects of Calcium Carbonate, Magnesium Oxide and Sodium Citrate Bicarbonate Health Supplements on the Urinary Risk Factors for Kidney Stone Formation
- Glycerol Metabolism and the Determination of Triglycerides –Clinical, Biochemical and Molecular Findings in Six Subjects
- Plasma Lipid Composition and LDL Oxidation
- Modified Method to Measure Nasal Potential Difference
- Towards Complete and Accurate Reporting of Studies of Diagnostic Accuracy: The STARD Initiative
- Novel and Traditional Biomarkers of Bone Turnover in Postmenopausal Women
- Urinary Plasma Protein Patterns in Acute Prostatitis
- Adequate Sampling in Cryoglobulinaemia: Recommended Warmly
- A New Modification of the Chiron ACS Assay for Total Prostate-Specific Antigen Achieves Equimolar Response Characteristics and Improves the Detection of Prostate Cancer
- Technical Performance and Diagnostic Utility of the New Elecsys® Neuron-Specific Enolase Enzyme Immunoassay
- Measurements of Complement Factor H-Related Protein (BTA-TRAK™ Assay) and Nuclear Matrix Protein (NMP22 Assay) – Useful Diagnostic Tools in the Diagnosis of Urinary Bladder Cancer?
- Erratum: The 18th International Congress of Clinical Chemistry and Laboratory Medicine. Special Supplement Abstracts Issue 2002
- Meetings and Awards